Hangzhou MSD Pharmaceutical

Hangzhou MSD Pharmaceutical is the primary manufacturing and packaging hub for MSD (known as Merck & Co. in the U.S. and Canada) in China. Located in the Hangzhou Economic and Technological Development Area, the facility is one of the most advanced pharmaceutical plants in the country and serves as a strategic center for the Asia-Pacific region. The company plays a vital role in MSD's "In China, For China" strategy, ensuring the stable supply of innovative medicines and vaccines to the local market. Its portfolio includes high-impact treatments in oncology, such as Keytruda, and essential vaccines like Gardasil. By integrating global quality standards with local production capabilities, Hangzhou MSD Pharmaceutical focuses on improving patient access to life-saving therapies across China.